Nerve blocks may cut opioid use after Open-Heart surgery
NCT ID NCT04985500
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study compares two types of nerve blocks—erector spinae plane (ESP) block and pecto-intercostal fascial (PIF) block—against standard care for controlling pain after heart surgery through the breastbone. About 225 adults aged 18–85 having planned cardiac surgery with a sternotomy will be randomly assigned to receive one of the blocks or no block. The main goal is to see if the blocks reduce opioid painkiller use and pain scores in the first 72 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- bupivacaine
- What this could lead to
- If successful, these nerve blocks could become a standard way to control pain after heart surgery, reducing the need for opioids.
- What could go wrong
- This is an early-phase trial with a modest number of participants. The blocks may not provide significant pain relief over standard care, and there is a small risk of local anesthetic toxicity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Early phase 1
The earliest testing in people: a first look at safety, in a very small group.
- Participants
-
225 people
The number who actually took part.
- Started
-
Jul 2021
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults 18-85 years old * Scheduled to undergo cardiac procedures involving sternotomy * All genders Exclusion Criteria: * ASA class V * Urgent or emergent surgery * Contraindications to administration of local anesthesia (e.g. local anesthetic allergy) * History of substance abuse or chronic opioid use * Patient refusal or inability to consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiac surgery are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mount Sinai Morningside Hospital
New York, New York, 10025, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood filter attached to Heart-Lung machine aims to stop ticagrelor bleeding
- Can a Pre-Surgery nerve block stop years of chest pain after heart surgery?
- Heart Fat's tiny messengers: scientists probe particles that may drive cardiac risk
- Can a simple platelet test predict who bleeds after heart surgery?
- Can a smartwatch outperform standard tools in tracking recovery after surgery?
- Minute-by-Minute urine tracking may sharpen fluid care after heart surgery